Study of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
Clinical trial NCT01060384 · COMPLETED
Trial details
- NCT number
- NCT01060384
- Sponsor
- University of Nebraska
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-29
- Primary completion
- 2016-10-25
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.